This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Stephenson A, Eggener SE, Bass EB, Chelnick DM, Daneshmand S, Feldman D, et al. Diagnosis and treatment of early stage testicular cancer: AUA guideline. J Urol. 2019 Aug;202(2):272–281.StephensonAEggenerSEBassEBChelnickDMDaneshmandSFeldmanDDiagnosis and treatment of early stage testicular cancer: AUA guideline2019Aug202227228110.1097/JU.000000000000031831059667Search in Google Scholar
https://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf. (date accessed: September 26, 2021).(date accessed: September 26, 2021).Search in Google Scholar
Hanna NH, Einhorn LH. Testicular cancer – discoveries and updates. N Engl J Med. 2014 Nov 20;371(21):2,005–16.HannaNHEinhornLHTesticular cancer – discoveries and updates2014Nov20371212,0051610.1056/NEJMra140755025409373Search in Google Scholar
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. European Association of Urology. guidelines on testicular cancer: 2015 update. Eur Urol. 2015 Dec;68(6):1,054–68.AlbersPAlbrechtWAlgabaFBokemeyerCCohn-CedermarkGFizaziKEuropean Association of Urology. guidelines on testicular cancer: 2015 update2015Dec6861,0546810.1016/j.eururo.2015.07.04426297604Search in Google Scholar
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. European Association of Urology. guidelines on testicular cancer: 2015 update. Eur Urol. 2015 Dec;68(6):1,054–68.AlbersPAlbrechtWAlgabaFBokemeyerCCohn-CedermarkGFizaziKEuropean Association of Urology. guidelines on testicular cancer: 2015 update2015Dec6861,0546810.1016/j.eururo.2015.07.044Search in Google Scholar
Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, et al. ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018 Aug 1;29(8):1,658–1,686.HoneckerFAparicioJBerneyDBeyerJBokemeyerCCathomasRESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up2018Aug12981,6581,68610.1093/annonc/mdy21730113631Search in Google Scholar
Laguna M.P, Albers P. Albrech W, et al. EAU guidelines on testicular cancer. EAU; 2019. Available from: http://www.uroweb.org/guideline/testicular-cancer/. Accessed February 12, 2020.LagunaM.PAlbersP.AlbrechWEAU2019Available from: http://www.uroweb.org/guideline/testicular-cancer/. Accessed February 12, 2020.Search in Google Scholar
Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, Fizazi K, et al. European Association of Urology. guidelines on testicular cancer: 2015 update. Eur Urol. 2015 Dec;68(6):1,054–68.AlbersPAlbrechtWAlgabaFBokemeyerCCohn-CedermarkGFizaziKEuropean Association of Urology. guidelines on testicular cancer: 2015 update2015Dec6861,0546810.1016/j.eururo.2015.07.044Search in Google Scholar
Cathomas R, Hartmann M, Krege S, Souchon R, Lorch A, Mayer F, et al. interdisziplinäre Arbeitsgruppe Hodentumore. Interdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients. Onkologie. 2011;34(1–2):59–64.CathomasRHartmannMKregeSSouchonRLorchAMayerFinterdisziplinäre Arbeitsgruppe HodentumoreInterdisciplinary evidence-based recommendations for the follow-up of testicular germ cell cancer patients2011341–2596410.1159/00032334621346388Search in Google Scholar
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, et al. International germ cell cancer classification update consortium. survival and new prognosticators in metastatic seminoma: results from the IGCCCG-Update Consortium. J Clin Oncol. 2021 May 10;39(14):1,553–1,562. doi: 10.1200/JCO.20.03292. Epub 2021 Mar 17. PMID: 33729863; PMCID: PMC8099394.BeyerJColletteLSauvéNDaugaardGFeldmanDRTandstadTInternational germ cell cancer classification update consortium. survival and new prognosticators in metastatic seminoma: results from the IGCCCG-Update Consortium2021May1039141,5531,56210.1200/JCO.20.03292Epub 2021 Mar 17. PMID: 33729863; PMCID: PMC8099394.809939433729863Open DOISearch in Google Scholar
Gilligan T, Lin DW, Aggarwal R, Chism D, Cost N, Derweesh IH, et al. Testicular cancer, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019 Dec;17(12):1,529–1,554.GilliganTLinDWAggarwalRChismDCostNDerweeshIHTesticular cancer, version 2.2020, NCCN clinical practice guidelines in oncology2019Dec17121,5291,55410.6004/jnccn.2019.005831805523Search in Google Scholar
SEER cancer statistics factsheets: testicular cancer. National Cancer Institute. Bethesda, MD. 2019. date accessed: September 26, 2021.National Cancer InstituteBethesda, MD2019date accessed: September 26, 2021.Search in Google Scholar
Bosl GJ, Motzer RJ. Testicular germ-cell cancer. N Engl J Med. 1997 Jul 24;337(4):242–53.BoslGJMotzerRJTesticular germ-cell cancer1997Jul2433742425310.1056/NEJM1997072433704069227931Search in Google Scholar
Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, et al. American Society of Clinical Oncology. American society of clinical oncology clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors. J Clin Oncol. 2010 Jul 10;28(20):3,388–404.GilliganTDSeidenfeldJBaschEMEinhornLHFancherTSmithDCAmerican Society of Clinical Oncology. American society of clinical oncology clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors2010Jul1028203,38840410.1200/JCO.2009.26.448120530278Search in Google Scholar
Jack RH, Davies EA, Møller H. Testis and prostate cancer incidence in ethnic groups in South East England. Int J Androl. 2007 Aug;30(4):215–20; discussion 220–1.JackRHDaviesEAMøllerHTestis and prostate cancer incidence in ethnic groups in South East England2007Aug30421520discussion 220–110.1111/j.1365-2605.2007.00777.x17573844Search in Google Scholar
Purdue MP, Devesa SS, Sigurdson AJ, McGlynn KA. International patterns and trends in testis cancer incidence. Int J Cancer. 2005 Jul 10;115(5):822–7.PurdueMPDevesaSSSigurdsonAJMcGlynnKAInternational patterns and trends in testis cancer incidence2005Jul101155822710.1002/ijc.2093115704170Search in Google Scholar
Biggs ML, Schwartz SM. Differences in testis cancer survival by race and ethnicity: a population-based study, 1973–1999 (United States). Cancer Causes Control. 2004 Jun;15(5):437–44.BiggsMLSchwartzSMDifferences in testis cancer survival by race and ethnicity: a population-based study, 1973–1999 (United States)2004Jun1554374410.1023/B:CACO.0000036443.95995.4015286463Search in Google Scholar
Sadeghi M, Ghoncheh M, Mohammadian-Hafshejani A, Gandomani HS, Rafiemanesh H, Salehiniya H. Incidence and mortality of testicular cancer and relationships with development in Asia. Asian Pac J Cancer Prev. 2016;17(9):4,251–4,257.SadeghiMGhonchehMMohammadian-HafshejaniAGandomaniHSRafiemaneshHSalehiniyaHIncidence and mortality of testicular cancer and relationships with development in Asia20161794,2514,257Search in Google Scholar
Feldman DR, Bosl GJ, Sheinfeld J, Motzer RJ. Medical treatment of advanced testicular cancer. JAMA. 2008 Feb 13;299(6):672–84. doi: 10.1001/jama.299.6.672. PMID: 18270356.FeldmanDRBoslGJSheinfeldJMotzerRJMedical treatment of advanced testicular cancer2008Feb1329966728410.1001/jama.299.6.672PMID: 18270356.18270356Open DOISearch in Google Scholar
Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA, Loehrer PJ. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med. 1987 Jun 4;316(23):1,435–40. doi: 10.1056/NEJM198706043162302. PMID: 2437455.WilliamsSDBirchREinhornLHIrwinLGrecoFALoehrerPJTreatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide1987Jun4316231,4354010.1056/NEJM198706043162302PMID: 2437455.2437455Open DOISearch in Google Scholar
de Wit R, Roberts JT, Wilkinson PM, de Mulder PH, Mead GM, Fosså SD, et al. Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council. J Clin Oncol. 2001 Mar 15;19(6):1,629–40. doi: 10.1200/JCO.2001.19.6.1629. PMID: 11250991.de WitRRobertsJTWilkinsonPMde MulderPHMeadGMFossåSDEquivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council2001Mar151961,6294010.1200/JCO.2001.19.6.1629PMID: 11250991.11250991Open DOISearch in Google Scholar
Culine S, Kerbrat P, Kramar A, Théodore C, Chevreau C, Geoffrois L, et al. Genito-Urinary Group of the French Federation of Cancer Center (GETUG T93BP). Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP). Ann Oncol. 2007 May;18(5):917–24.CulineSKerbratPKramarAThéodoreCChevreauCGeoffroisLGenito-Urinary Group of the French Federation of Cancer Center (GETUG T93BP). Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP)2007May1859172410.1093/annonc/mdm06217351252Search in Google Scholar
Fankhauser CD, Sander S, Roth L, Beyer J, Hermanns T. Improved survival in metastatic germ-cell cancer. Ann Oncol. 2018 Feb 1;29(2):347–351.FankhauserCDSanderSRothLBeyerJHermannsTImproved survival in metastatic germ-cell cancer2018Feb129234735110.1093/annonc/mdx74129161363Search in Google Scholar
Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, et al. International Germ Cell Cancer Classification Update Consortium. predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG Update Consortium. J Clin Oncol. 2021 May 10;39(14):1,563–1,574.GillessenSSauvéNColletteLDaugaardGde WitRAlbanyCInternational Germ Cell Cancer Classification Update Consortium. predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG Update Consortium2021May1039141,5631,57410.1200/JCO.20.03296809940233822655Search in Google Scholar
Nguyen MM, Ellison LM. Testicular cancer patterns in Asian-American males: an opportunity for public health education to impact outcomes. Urology. 2005 Sep;66(3):606–9.NguyenMMEllisonLMTesticular cancer patterns in Asian-American males: an opportunity for public health education to impact outcomes2005Sep663606910.1016/j.urology.2005.03.06916140087Search in Google Scholar